Sun et al. reported that the expression level of SAMMSON is closely related to distant metastasis, lymph node metastasis, and clinical stage, and patients with high expression of SAMMSON have a low overall survival time. The gene discussed is SAMMSON; the disease is metastatic malignant neoplasm in the lymph nodes.